Knott P G, D'Aprile A C, Henry P J, Hay D W, Goldie R G
Department of Pharmacology, University of Western Australia, Nedlands.
Br J Pharmacol. 1995 Jan;114(1):1-3. doi: 10.1111/j.1476-5381.1995.tb14895.x.
[125I]-endothelin-1 ([125I]-ET-1) binding was assessed by autoradiography in peripheral airway smooth muscle and alveolar wall tissue in human non-asthmatic and asthmatic peripheral lung. Levels of specific binding to these structures were similar in both non-asthmatic and asthmatic lung. The use of the receptor subtype-selective ligands, BQ-123 (ETA) and sarafotoxin S6c (ETB), demonstrated the existence of both ETA and ETB sites in airway smooth muscle and in alveoli. In airway smooth muscle from both sources, the great majority of sites were of the ETB subtype. Quantitative analyses of asthmatic and non-asthmatic alveolar wall tissue demonstrated that 29-32% of specific [125I]-ET-1 binding was to ETA sites and 68-71% was to ETB sites. Thus, asthma was not associated with any significant alteration in the densities of ETA and ETB receptors in peripheral human lung.
采用放射自显影法评估[125I]-内皮素-1([125I]-ET-1)在人非哮喘和哮喘外周肺的外周气道平滑肌及肺泡壁组织中的结合情况。非哮喘和哮喘肺中这些结构的特异性结合水平相似。使用受体亚型选择性配体BQ-123(ETA)和sarafotoxin S6c(ETB),证实气道平滑肌和肺泡中均存在ETA和ETB位点。在来自这两种来源的气道平滑肌中,绝大多数位点为ETB亚型。对哮喘和非哮喘肺泡壁组织的定量分析表明,特异性[125I]-ET-1结合的29%-32%是与ETA位点结合,68%-71%是与ETB位点结合。因此,哮喘与人类外周肺中ETA和ETB受体密度的任何显著改变均无关。